HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Everett E Vokes Selected Research

5,6-dihydro-5-azacytidine

4/2008Response to the methylation inhibitor dihydro-5-azacytidine in mesothelioma is not associated with methylation of p16INK4a: results of cancer and leukemia group B 159904.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Everett E Vokes Research Topics

Disease

121Neoplasms (Cancer)
11/2021 - 02/2001
70Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2022 - 02/2001
53Head and Neck Neoplasms (Head and Neck Cancer)
01/2022 - 07/2002
38Squamous Cell Carcinoma of Head and Neck
01/2022 - 05/2003
31Leukemia
07/2017 - 02/2001
25Small Cell Lung Carcinoma (Small Cell Lung Cancer)
01/2021 - 03/2004
21Lung Neoplasms (Lung Cancer)
01/2022 - 08/2003
20Disease Progression
01/2022 - 02/2003
14Fatigue
11/2020 - 01/2004
13Neutropenia
11/2020 - 04/2004
11Diarrhea
10/2019 - 01/2004
9Neoplasm Metastasis (Metastasis)
01/2022 - 12/2004
9Malignant Mesothelioma
11/2020 - 10/2008
7Anemia
11/2020 - 05/2003
7Hypertension (High Blood Pressure)
10/2019 - 10/2008
7Thrombocytopenia (Thrombopenia)
01/2017 - 10/2002
7Hemorrhage
01/2017 - 01/2004
7Exanthema (Rash)
01/2017 - 01/2004
6Colorectal Neoplasms (Colorectal Cancer)
06/2012 - 07/2004
5Adenocarcinoma
03/2014 - 08/2004
5Esophageal Neoplasms (Esophageal Cancer)
01/2013 - 02/2001
5Weight Loss (Weight Reduction)
09/2010 - 01/2006
4Carcinoma (Carcinomatosis)
01/2021 - 01/2004
4Mucositis
01/2017 - 08/2004
4Squamous Cell Neoplasms (Squamous Cell Cancer)
01/2016 - 09/2003
4Carcinogenesis
03/2014 - 08/2003
4Squamous Cell Carcinoma (Epidermoid Carcinoma)
03/2014 - 10/2009
4Esophagitis
01/2013 - 10/2002
4Nausea
06/2012 - 01/2010
4Pancreatic Neoplasms (Pancreatic Cancer)
02/2012 - 11/2005
4Thrombosis (Thrombus)
11/2011 - 04/2008
4Mesothelioma
03/2011 - 06/2006
3Oropharyngeal Neoplasms
01/2022 - 07/2007
3Pneumonia (Pneumonitis)
01/2022 - 09/2008
3Tongue Neoplasms (Tongue Neoplasm)
01/2018 - 01/2010
3Body Weight (Weight, Body)
11/2016 - 07/2015
3Dehydration (Water Stress)
01/2013 - 09/2008
3Renal Cell Carcinoma (Grawitz Tumor)
05/2012 - 01/2004
3Vomiting
12/2011 - 09/2008
3Prostatic Neoplasms (Prostate Cancer)
07/2011 - 05/2004

Drug/Important Bio-Agent (IBA)

26Paclitaxel (Taxol)FDA LinkGeneric
01/2021 - 02/2001
25ErbB Receptors (EGF Receptor)IBA
11/2019 - 05/2003
24Carboplatin (JM8)FDA LinkGeneric
01/2021 - 10/2002
21PlatinumIBA
01/2022 - 03/2006
19Cisplatin (Platino)FDA LinkGeneric
01/2021 - 02/2001
14NivolumabIBA
01/2022 - 07/2015
14Cetuximab (Erbitux)FDA Link
01/2021 - 02/2004
13Biomarkers (Surrogate Marker)IBA
11/2021 - 01/2011
13Docetaxel (Taxotere)FDA Link
01/2021 - 02/2001
12Fluorouracil (Carac)FDA LinkGeneric
01/2016 - 01/2003
11Irinotecan (Camptosar)FDA LinkGeneric
01/2020 - 04/2004
11Hydroxyurea (Hydrea)FDA LinkGeneric
01/2016 - 01/2003
10Bevacizumab (Avastin)FDA Link
10/2019 - 11/2005
10Etoposide (VP 16)FDA LinkGeneric
10/2019 - 03/2004
10GemcitabineFDA Link
07/2012 - 02/2001
9Erlotinib Hydrochloride (CP 358,774)FDA Link
10/2019 - 01/2004
9Proteins (Proteins, Gene)FDA Link
03/2014 - 02/2007
9Phosphotransferases (Kinase)IBA
03/2014 - 11/2005
8Gefitinib (Iressa)FDA Link
09/2012 - 05/2003
8Tyrosine Kinase InhibitorsIBA
06/2012 - 01/2004
7Pemetrexed (MTA)FDA Link
11/2020 - 01/2007
6Pharmaceutical PreparationsIBA
01/2020 - 01/2004
6Protein-Tyrosine Kinases (Tyrosine Kinase)IBA
06/2015 - 08/2005
5DNA (Deoxyribonucleic Acid)IBA
01/2022 - 09/2009
5veliparibIBA
11/2021 - 07/2011
5Sunitinib (Sutent)FDA Link
01/2017 - 10/2010
5Biological ProductsIBA
02/2015 - 02/2003
5Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA
01/2015 - 01/2011
4Monoclonal AntibodiesIBA
01/2018 - 08/2005
4Cyclooxygenase 2 (Cyclooxygenase-2)IBA
07/2017 - 08/2003
4tyrosine receptor (receptor, tyrosine)IBA
03/2014 - 02/2007
4Oxaliplatin (Eloxatin)FDA LinkGeneric
06/2012 - 12/2004
4Vinorelbine (Navelbine)FDA LinkGeneric
10/2002 - 02/2001
3Poly(ADP-ribose) Polymerase InhibitorsIBA
01/2021 - 07/2011
3ElectrolytesIBA
01/2020 - 01/2004
3ParaffinIBA
01/2020 - 01/2010
3Formaldehyde (Formol)FDA Link
01/2020 - 01/2010
3Celecoxib (Celebrex)FDA Link
07/2017 - 02/2008
3Methotrexate (Mexate)FDA LinkGeneric
01/2017 - 04/2009
3CrizotinibIBA
12/2015 - 04/2009
3LigandsIBA
10/2015 - 12/2008
3Proto-Oncogene Proteins c-metIBA
02/2014 - 12/2008
3Sorafenib (BAY 43-9006)FDA Link
01/2013 - 04/2010
3Dasatinib (BMS 354825)FDA Link
06/2012 - 03/2010
3TOR Serine-Threonine KinasesIBA
05/2012 - 06/2010
3Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA
03/2011 - 10/2008
3Protein Kinase CIBA
03/2011 - 02/2003
3Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
03/2011 - 05/2004

Therapy/Procedure

73Therapeutics
01/2022 - 07/2002
70Drug Therapy (Chemotherapy)
01/2022 - 02/2001
50Radiotherapy
01/2021 - 02/2001
50Chemoradiotherapy
01/2021 - 10/2002
29Induction Chemotherapy
01/2022 - 02/2001
8Re-Irradiation
10/2011 - 03/2005
5Adjuvant Chemotherapy
01/2022 - 11/2006
5Immunotherapy
10/2021 - 01/2017
4Combined Modality Therapy
01/2019 - 08/2003
4Neck Dissection (Radical Neck Dissection)
11/2009 - 05/2004
3Drug Tapering
01/2022 - 08/2004
3Conformal Radiotherapy
11/2011 - 05/2008